HiPAL Pro is a language‑agnostic tool that supports the diagnosis of Alzheimer’s disease (AD) and cognitive impairment. By assessing memory and response speed, it generates objective, quantitative predicted MMSE and ADAS‑Cog scores for interpretation by licensed medical professionals. Repeated administration enables comparisons with previous results for the same patient, supporting longitudinal tracking of cognitive function.
HiPAL Pro also functions as a cognitive screening tool for clinical and research trials. By predicting MMSE and ADAS‑Cog scores, it can help identify suitable candidates for specific trials. In clinical practice, results interpreted by qualified healthcare professionals help determine when further cognitive evaluation is warranted.
Designed for adults, HiPAL Pro is suitable for asymptomatic individuals, symptomatic patients, and those diagnosed with Alzheimer’s disease. It is self‑administered under supervision and can be used in waiting rooms or other distraction‑free environments. Prescription and evaluation/interpretation by licensed medical professionals are mandatory.
Assessments can be restarted to repeat interrupted sessions. To mitigate practice effects, HiPAL Pro should not be administered more frequently than every three months. Scores may be influenced by degraded motor skills and by medications that affect reaction time, memory, or other cognitive functions. The tool is not suitable for individuals with severe visual impairment.
At HiPAL Pro, we are committed to advancing cognitive assessment with a sophisticated yet user‑friendly platform. The assessment captures aspects of memory, conscious learning, metacognitive judgement, reaction time, and speed–accuracy trade‑off to support comprehensive evaluation.
Experience the next generation of cognitive screening technology—HiPAL Pro. Designed to be sensitive, this innovative solution aims to identify early changes in cognitive function.
HiPAL Pro integrates as a cognitive assessment tool into current diagnostic pathways and has the potential to transform the assessment of cognitive impairment.
Supported by clinical validation and regulatory listing, HiPAL Pro delivers reliable scoring to support decision‑making in clinical practice and research settings.
We are dedicated to supporting specialist centres and clinicians by reducing assessment time and burden, and by aiding earlier identification of cognitive impairment. Join us in adopting a modern approach to cognitive assessment.
Discover the future of cognitive assessment with HiPAL Pro. Connect with our community of healthcare professionals who are advancing cognitive screening and improving patient outcomes. Contact us to integrate HiPAL Pro into your practice.
Explore our Cognitive Assessment Insights to stay current with research and trends in cognitive screening. To hear real world experiences, visit Expert Experience with HiPAL Pro for first hand clinician accounts of practice transformation. Our Learning & Resources section offers educational materials, training modules, and interactive tools to support ongoing professional development.
Want to keep informed? For updates on HiPAL Pro, please sign up to our mailing list.
